CDSCO License for Applicator for neck remote after loading brachytherapy
Medical Device Information
Intended Use
A remote controlled brachytherapy applicator specifically designed for neck radiation therapy. It is designed to be temporarily implanted in the neck tissues. It serves as a guide for computer-controlled temporary placement and removal of a single or multiple therapeutic radiation sources.

Introduction to Applicator for Neck Remote After Loading Brachytherapy and Regulatory Importance
The Applicator for Neck Remote After Loading Brachytherapy is a specialized Class C medical device designed for targeted radiotherapy in the neck region. It plays a critical role in cancer treatment by enabling precise, computer-controlled placement and removal of radioactive sources within neck tissues. Given its invasive nature and therapeutic application, regulatory compliance is paramount to ensure patient safety, device efficacy, and market authorization in India.
At our consultancy, with over 25 years of experience guiding 500+ companies, we understand the nuances of obtaining CDSCO licenses for complex Class C devices in the radiotherapy category. This device’s classification underlines the need for stringent regulatory adherence, including thorough documentation, laboratory testing, and audits before commercialization.
CDSCO Regulatory Framework for Radiotherapy Applicators
The Central Drugs Standard Control Organization (CDSCO) governs medical device regulation in India under the Medical Device Rules 2017. Radiotherapy devices like the neck remote after loading brachytherapy applicator fall under the higher risk classes (Class C), requiring approval from the Central Licensing Authority.
Regulatory oversight covers manufacturing, import, quality management, and post-market surveillance. The CDSCO ensures the device complies with safety, performance, and labeling standards before granting market access. Compliance also aligns with the Essential Principles of Safety and Performance as mandated.
Risk Classification and License Requirements for Class C Devices
This applicator is classified as a Class C device due to its invasive nature and the critical radiotherapy use. According to CDSCO guidelines:
- Class C devices require a manufacturing license (MD9) or import license (MD15) from the Central Licensing Authority.
- The regulatory process involves a test license, product testing in government-approved laboratories, extensive document submission, and a CDSCO audit.
- The license application is submitted on the CDSCO MD Online Portal.
Understanding this classification is essential to prepare the right documentation and anticipate timelines and costs effectively. For detailed classification, you can refer to our Medical Device Classification guide.
Manufacturing License Process for Class C Devices (MD9)
Manufacturers intending to produce the neck brachytherapy applicator in India must apply for an MD9 license. The process is detailed and involves several critical steps:
Test License Application (Form MD13): Before full license application, a test license is mandatory to facilitate product testing. This step typically takes about 1.5 to 2 months.
Product Testing: The device must be tested in government-approved laboratories to verify safety and performance. Refer to the list of Testing Laboratories accredited by CDSCO.
Document Preparation: Comprehensive documentation including Device Master File, Plant Master File, Essential Principles Checklist, Risk Management File, and Quality Management System (QMS) documents must be prepared.
License Application (Form MD7): Submit the manufacturing license application via the CDSCO portal.
CDSCO Audit: An on-site audit by CDSCO inspectors evaluates manufacturing practices, QMS implementation, and compliance with regulatory requirements.
Query Resolution: Address any queries raised during the audit or document review promptly.
Grant of License (Form MD9): Upon successful completion of all steps, the license is granted.
For an in-depth step-by-step guide, our MD9 License Guide offers practical insights.
Manufacturing License Documents Required for the Applicator
For this Class C radiotherapy device, the following documents are essential:
- Company Constitution and Incorporation Certificates
- Proof of Ownership or Lease Agreement for Manufacturing Premises
- Technical Staff Qualification and Experience Details
- Fire and Pollution No Objection Certificates (NOCs)
- Device Master File (DMF) detailing design, specifications and manufacturing process (see our Device Master File Guide)
- Plant Master File outlining the manufacturing environment and equipment (refer to our Plant Master File Guide)
- Essential Principles Checklist demonstrating compliance with safety and performance standards
- Risk Management File adhering to ISO 14971 principles (more on Risk Management)
- Product Test Reports from CDSCO-approved labs
- Device Labeling and Instructions For Use (IFU)
- Quality Management System documentation (ISO 13485:2016 compliant)
Ensuring completeness and accuracy of these documents significantly reduces processing time and audit queries.
Import License Process for Class C Devices (MD15)
Importers of the applicator must secure an MD15 license from CDSCO’s Central Licensing Authority. Unlike manufacturing licenses, no test license is required. The import license process includes:
Preparation of Documents: Including Manufacturing License from the country of origin, Free Sale Certificate, ISO 13485:2016 certification, CE Certificate, Device and Plant Master Files, Wholesale Drug License, and Company Constitution.
Application Submission: File Form MD14 for import license through the CDSCO MD Online Portal.
Document Scrutiny: CDSCO reviews the application and supporting documents.
Query Resolution: Promptly address any clarifications or additional information requests.
Grant of License (Form MD15): Upon approval, the import license is issued.
For further guidance, please consult our comprehensive Import License Guide.
Import License Documents Required
Specifically, for the Applicator for Neck Remote After Loading Brachytherapy, these documents are required:
- Valid Manufacturing License from the manufacturing country
- Free Sale Certificate or Certificate of Market Authorization
- ISO 13485:2016 certification
- CE Certificate or equivalent conformity assessment
- Device Master File and Plant Master File
- Wholesale Drug License (if applicable)
- Company Constitution and Details
- Labeling and IFU relevant to Indian market
Completing these with precision expedites the license grant process.
Timeline and Processing Duration
For Class C devices like the brachytherapy applicator, expect the following timelines:
- Manufacturing License (MD9): Approximately 4 to 5 months total, including 1.5 to 2 months for test license, testing, document preparation, audit, and query resolution.
- Import License (MD15): Around 5 to 6 months, considering document scrutiny and query handling.
These timelines may vary depending on document quality, audit scheduling, and responsiveness to queries. Early preparation and expert consultation can streamline approvals.
Government Fees and Costs
The cost structure for licensing this Class C device is as follows:
MD9 Manufacturing License:
- Application fee: ₹50,000
- Per product fee: ₹1,000
MD15 Import License:
- Site fee: $3,000 (~₹2,40,000)
- Per product fee: $1,500 (~₹1,20,000)
Additional costs include testing laboratory fees, audit charges by notified bodies or CDSCO inspectors, and consultancy fees if applicable. Budgeting for these ahead of time avoids surprises.
Common Challenges and Solutions
Manufacturers and importers often face the following issues:
Incomplete Documentation: Missing Device Master File details or risk management documents delay processing. Solution: Use comprehensive checklists and expert review.
Testing Delays: Limited availability at government-approved labs can stall timelines. Solution: Schedule testing early and explore alternative approved labs from the Testing Laboratories list.
Audit Non-compliance: Poorly prepared manufacturing sites or QMS implementation issues can lead to adverse audit findings. Solution: Conduct internal audits and train staff before CDSCO inspection.
Query Response Delays: Slow replies to CDSCO queries prolong approval. Solution: Designate a regulatory liaison to ensure prompt communication.
Cost Underestimation: Under-budgeting for fees and testing costs impacts project timelines. Solution: Prepare detailed financial plans including contingency.
Expert Consultation and Support
Our extensive experience with over 500 successful CDSCO license applications positions us as your ideal regulatory partner. We offer:
- Tailored document preparation support
- End-to-end application submission and tracking
- Pre-audit readiness assessments
- Expert guidance on compliance with the Medical Device Rules and Essential Principles
- Liaison services with CDSCO and notified bodies
Partnering with experts mitigates risks of rejection and accelerates market entry.
Getting Started with Your CDSCO License Application
To initiate your application for the Applicator for Neck Remote After Loading Brachytherapy:
Assess Device Classification: Confirm your device is Class C and determine if your strategy involves manufacturing or importing.
Compile Required Documentation: Begin gathering all technical and legal documents, referencing our guides on Device and Plant Master Files.
Schedule Product Testing: Contact government-approved labs early for test license and testing timelines.
Register on the CDSCO MD Online Portal: Set up your account to submit applications electronically, ensuring all digital documents are in order.
Engage Expert Support: Consider consulting experienced regulatory professionals to review your submissions and prepare for audits.
Submit Application: Upload your complete dossier and monitor application status regularly.
Starting early and following a structured approach is key to smooth licensing. Visit the CDSCO MD Online Portal today to take the first step toward Indian market entry.
By adhering to these comprehensive steps and leveraging expert insights, manufacturers and importers can confidently navigate the CDSCO licensing pathway for this critical radiotherapy applicator, ensuring timely compliance and successful commercialization.